Mount Sinai Health System
New York, NY
Dr. William K. Oh is Clinical Professor of Medicine in the Division of Hematology/Medical Oncology at The Tisch Cancer Institute of the Icahn School of Medicine at Mount Sinai. He is an expert in the management of genitourinary malignancies, including prostate, renal, bladder and testicular cancers. He had had leadership roles as CMO of Sema4, a genomics and AI company, as well as CMO at Prostate Cancer Foundation. From 2009-2020, he was Chief of the Division of Hematology/Medical Oncology at the Mount Sinai Health System and Deputy Director of The Tisch Cancer Institute, an NCI-designated cancer center, at Mount Sinai. He spent 14 years at Harvard Medical School and Dana-Farber Cancer Institute in Boston, including service as Clinical Director of GU Oncology and Associate Professor of Medicine.
Dr. Oh has authored more than 350 original articles, reviews and book chapters on topics relating to prostate, renal, bladder and testicular cancers and has edited 3 books on prostate cancer. He has served in key invited roles for ASCO, ACS and AUA, including the Guidelines Committee for Castration Resistant Prostate Cancer. In addition to reviewing for prominent journals such as the New England Journal of Medicine, Journal of Clinical Oncology, and Cancer. He was inducted into the prestigious American Society for Clinical Investigation (ASCI) and has been repeatedly selected as a Top Doctor in New York Magazine, Castle Connolly, Best Doctors and Super Doctors.
Disclosures:
Saturday, September 28, 2024
3:35 PM – 3:55 PM ET